Heart Failure Patients Optimistic About Life Expectancy

An article published in the June 4 issue of JAMA
reports on the discordance between the clinical predictions and patient
expectations of life expectancy and survival of heart failure patients.
Larry A. Allen, M.D., M.H.S. (Duke Clinical Research Institute, Durham,
N.C.) and colleagues find that younger patients and those with more
severe disease significantly overestimate their remaining life span.

Every year in the United States, heart failure directly leads to 55,000
deaths and indirectly leads to 230,000 deaths. Patients with
symptomatic heart failure have a median life expectancy of less than 5
years, even with the advances in care that exist today. About 90% of
patients with the most advance disease die within one year. However, a
patient’s prognosis is dependent on several factors, and researchers
have developed several models to predict survival times for heart
failure patients.

The issue on which Allen and colleagues focus is whether or not
patients understand their prognosis after a heart failure diagnosis.
The authors note that, “Patient perception of prognosis is important
because it fundamentally influences medical decision making regarding
medications, devices, transplantation, and end-of-life care.”

To investigate the topic, the researchers conducted a study to compare
personal life expectancy predictions of 122 heart failure patients (who
were not confined to a bed) to the predictions estimated by statistical
models. The patients were about 62 years old and 47% African American.
About 42% of them were classified as New York Heart Association [NYHA]
class III or IV – an indication of more severe heart failure. The
patients were asked what they predicted their life expectancy to be,
and the researchers compared the responses with estimates computed
using the Seattle Heart Failure Model (SHFM).

Patients, on average, predicted their life expectancy to be 13.0 years
while the model predicted an average of 10.0 years. The researchers
found that most patients (63%) overestimated their life expectancy
compared to what was predicted by the SHFM. Using the ratio of
patient-predicted to model-predicted life expectancy (life expectancy
ratio or LER) the authors found that the median overestimation of
predicted future survival was 40% – an LER of 1.4. Patients who had a
higher LER did not necessarily have improved survival, and 29% of
patients died within a median follow-up period of 3.1 years. Patients
who were most likely to overestimate their life expectancy were
younger, less depressed, and had more severe disease.

Regarding the finding that there was little relationship between
patient-predicted and model-predicted life expectancy, the authors
conclude:

“The exact reasons for this incongruity are unknown but they may
reflect hope or may result from inadequate communication between
clinicians and their patients about prognosis. Because differences in
expectations about prognosis could affect decision making regarding
advanced therapies and end-of-life planning, further research into both
the extent and the underlying causes of these differences is warranted.
Whether interventions designed to improve communication of prognostic
information between clinicians and patients would improve the process
of care in heart failure should be tested in appropriately designed
clinical trials.”

An accompanying editorial, written by Clyde W. Yancy, M.D. (Baylor
University Medical Center, Dallas), discusses concern for the accuracy
of clinical prediction models like the SHFM.

“Currently, there is insufficient precision in the prognostication of
heart failure, and decision making at the end of life is perhaps the
most personalized of all decision making in medicine. Although
well-intended and carefully constructed tools and awareness of the
natural history of disease are helpful, it is the primacy of the
patient-physician interface that must prevail. Until these questions
are fully addressed, it is best to avoid adopting an imprecise method,
instead continuing to embrace the individualized decision-making
process guided by physician judgment that incorporates all patient care
considerations,” he concludes.

Discordance Between Patient-Predicted and Model-Predicted Life
Expectancy Among Ambulatory Patients With Heart Failure

Larry A. Allen; Jonathan E. Yager; Michele Jonsson Funk; Wayne C. Levy;
James A. Tulsky; Margaret T. Bowers; Gwen C. Dodson; Christopher M.
O’Connor; G. Michael Felker
JAMA (2008). 299[21]:2533-2542.
Click
Here to View Abstract

Written by: Peter M Crosta

Leave a Reply

Your email address will not be published. Required fields are marked *